awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q41145898-DD23866E-E8E5-4552-A318-6F14827D2F7C
Q41145898-DD23866E-E8E5-4552-A318-6F14827D2F7C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41145898-DD23866E-E8E5-4552-A318-6F14827D2F7C
Progression-free survival of first-line treatment with molecular-targeted therapy may be a meaningful intermediate endpoint for overall survival in patients with metastatic renal cell carcinoma.
P31
Q41145898-DD23866E-E8E5-4552-A318-6F14827D2F7C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41145898-DD23866E-E8E5-4552-A318-6F14827D2F7C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ea7b510423e095cfb2f0900a545b2bb2a7b3b02d
P31
scholarly article